While personally “disappointed” about the election’s outcome, current FDA Commissioner Robert Califf, M.D., has laid out the ...

FDA Chief Robert Califf reflects on potential changes as Trump's re-election looms, expressing disappointment and ...

The agency’s ability to hire and retain skilled employees may be in jeopardy given Trump ally Robert F. Kennedy Jr.’s ...

Staff turnover is typical when a new administration comes in, and a significant number of FDA employees similarly considered ...

Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty ...

Kennedy has been most vocal about the FDA, an agency that oversees nearly $3 trillion in medicines, food and tobacco products ...

Robert F. Kennedy Jr.'s nomination to lead HHS is causing cautious concern among investors. Here's which companies and stocks ...

Food and Drug Administration commissioner Robert Califf said he was “disappointed” with the presidential election result and ...

Anxious and bewildered, some drugmakers are reaching out to their lobbyists about how Robert Kennedy’s pending nomination ...

Robert M. Califf, M.D., is the commissioner of the Food and Drug Administration. Haider Warraich, M.D., is the senior clinical adviser for chronic disease to the FDA commissioner. Jim Jones is the ...

At a cancer research event Tuesday, FDA Commissioner Robert Califf said he was “disappointed” with the election results and ...

Robert F. Kennedy Jr., one of President-elect Donald Trump’s advisers on health, is taking aim at the agency’s oversight on ...